Sentences with phrase «of vaccine development at»

Jury member Penny Heaton, director of vaccine development at the Bill & Melinda Gates Foundation, said CureVac's RNA technology had «the potential for a large and positive impact on public health,» in a statement released by the company on 10 March.

Not exact matches

At 10:30 a.m., U.S. Senate Minority Leader U.S. Chuck Schumer will urge the U.S. Department of Health and Human Services to increase research, vaccine development and treatment strategies to help stamp out tick - borne diseases like Lyme disease, Albany Medical Center, B Entry, Patient Pavilion, Floor E, corner of Myrtle Avenue and New Scotland Avenue, Albany.
Femi Makinde in this piece examines the efforts of the National Primary Health Care Development Agency, Lions Club and international agencies at stopping measles in Osun State Measles which is an infectious disease caused by the rubeola virus can be fatal but the good news is that it can be prevented by vaccine.
When he returned to the United States to take a second postdoc at the Center for Vaccine Development at the University of Maryland School of Medicine in Baltimore, he also took a second job, teaching microbiology in the evenings, at nearby Anne Arundel Community College.
At Penn, two different Zika vaccine candidates are in various stages of development.
Opportunities exist for people with expertise including infectious diseases, epidemiology, molecular biology, immunology, and biostatistics,» says Eileen Barry, with the Center for Vaccine Development at the University of Maryland in Baltimore.
The flurry of action — at breakneck speed compared with most vaccine development — shows how a health emergency and a guaranteed global market can prod this process to move a lot faster than usual, with streamlined approvals and millions of dollars in government support.
A spokesperson for the journal's publisher, PLOS, wrote in an email that a committee on «dual use research of concern» at the journal unanimously agreed that the benefits of publication, including «the potential improvements in vaccine development» outweighed the risks.
The author discusses the production of Salk vaccine at Cutter Laboratories, the tragic effects of the inadvertent injection of 200,000 people with live virulent polio virus, the subsequent legal proceedings, and the shadow those have cast on the development of new vaccines.
The research, led by a scientist at the University of Maryland School of Maryland (UM SOM) Center for Vaccine Development (CVD), was published recently in the journal Proceedings of the National Academy of Sciences.
After stepping down as head of the Centers for Disease Control and Prevention (CDC) almost a year ago, Julie Gerberding has a new gig: She will preside over vaccine development at the drug giant Merck.
A vaccine under development prevents adhesion proteins at the tips of spaghettilike pili on UTI - causing bacteria (left) from latching onto host cells.
The first live - attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from The University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil.
Next year, UTMB will start building a high - containment lab that can handle even the most dangerous viruses — one of only a handful in the U.S. With that capacity, and the expertise concentrated at UTMB, the new center should «make some very important contributions» to vaccine development, La Montagne predicts.
This makes the development of an effective vaccine to protect against infection, as well as antiviral therapy to combat already - existing infections, particularly challenging,» says Dr. Grant Hansman, a virologist who leads the CHS Research Group on Noroviruses at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University.
The study included 124 newly diagnosed patients at 25 clinical trial sites in the U.S. Two - thirds of the patients were treated with ICT - 107, an experimental vaccine based on immune system cells called dendritic cells that were exposed to six synthetic proteins, or antigens, known to be involved in GBM development.
«The biggest issue will be price,» says John Schiller, a senior investigator at the National Cancer Institute, who did some of the early work that led to the vaccine's development.
«The idea basically is that a vaccine should induce antibodies T cells immune response, that would neutralise HIV in all of its forms,» explains Ulrich Fruth, vaccine development and evaluation team leader at the World Health Organisation, in Geneva, Switzerland.
The researchers are now looking at how ICOS signals can be altered to diminish autoimmune disorders and augmented for more effective vaccine development, and are beginning research on how ICOS signaling may benefit Chimeric Antigen Receptor - T cell (CAR - T) therapies, which involves engineering of patient's own immune cells to recognize and attack their cancers.
«It's probably the furthest along in development of the prophylactic vaccines, but a lot of us don't think such a vaccine will work so well,» says Jake Liang at the National Institute of Diabetes and Digestive and Kidney Diseases.
In October, as senior citizens and others at high risk from flu waited in long lines for shots after half of the United States» vaccine supply for the season was lost, epidemiologists were already on high alert because of an ominous development halfway around the world.
«The Meningitis Vaccine Project is one of the greatest success stories in public health,» said Dr. Chris Elias, President of the Global Development Program at the Bill & Melinda Gates Foundation, a major funder of the project.
Reported in the January 16, 2015 issue of the journal Science, the new findings provide a cautionary tale for the development of vaccines aimed at eliciting robust CD4 T cell immunity against chronic infections, including HIV.
«The pace of preclinical and early clinical development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research at BIDMC.
«We have been struggling to use traditional vaccine - development approaches with these big pathogens,» says Julie Louise Gerberding, president of the vaccine division at Merck and former director of the US Centers for Disease Control and Prevention.
These observations helped scientists characterize the biology of HPV infection at each anatomic site and aid in the development of HPV prevention strategies, including the vaccines Cervarix ® and Gardasil ®.
Janda's team at the Scripps Research Institute has prepared a vaccine that is effective against fentanyl and has made progress in the development of a combination vaccine that offers protection from both heroin and fentanyl.
«We have learned in that period of time how formidable an adversary HIV is,» says immunologist Wayne Koff, senior vice president for research and development at the International AIDS Vaccine Initiative (IAVI).
Today and tomorrow, Ebola scientists and representatives from companies and regulatory bodies are meeting at the World Health Organization's (WHO's) headquarters in Geneva, Switzerland, to discuss how to speed up clinical development of vaccines, a process that normally takes years.
At the meeting, GlaxoSmithKline (GSK) of Rixensart, Belgium, which has the vaccine furthest in development, spelled out how it might scale up production in parallel with the safety and efficacy trials now under way so that the product could be ready for wider distribution by April if warranted.
Several countries and organizations at the meeting offered to help support development and testing of the vaccines, Kieny said.
In a previous study, investigators at the Cancer Institute showed that using a vaccine treatment for bladder and breast cancer tumors in laboratory models resulted in a reversal of the traditional immune blockade, as well as the development of tumor specific immunity throughout the body.
Richt and Ma presented the project along with the proof - of - concept vaccination methods at a recent meeting of stakeholders and leaders in the U.S. agricultural industry, including the chicken and turkey industries, who will be helpful in the further development and adoption of the NDV - H5Nx vaccine.
The studies, which appear online today in the Proceedings of the National Academy of Sciences, are «scientifically interesting,» says Mark Tompkins, who studies influenza vaccine development at the University of Georgia, Athens.
The vaccine technology clearly has a biological effect that prevents dengue,» says Derek Wallace, regional director of clinical development for Sanofi Pasteur, the French pharmaceutical firm developing the vaccine, who reported results online today at The Lancet.
The binding site «is an excellent candidate for vaccine development», says Chien - Te Tseng of the University of Texas Medical Branch at Galveston, who collaborated on Couch's study of SARS vaccines.
This new interest led to a student rotation at the Biomedical Center, which is focused on the development of a vaccine against HIV.
Working with a world - leading group at the University of Connecticut in the USA, who pioneered the development of self - assembling protein nanoparticles (SAPNs) for vaccine design, they have used advanced mathematical calculations to create a complete picture of the surface morphology of these particles.
Vinetz said the next step will be to begin exploiting the genomic information «for vaccine and diagnostics development, experimental approaches to understanding mechanisms of disease pathogenesis and how Leptospira persist in the environment, all critical for developing new public health interventions aimed at reducing the global impact of this important but neglected zoonotic disease.»
Previously, Torsten worked for more than 10 years at GlaxoSmithKline Vaccines where he was the Global Head of the Vaccines Transactions Team with responsibility for all vaccine business development activities ranging from collaborations, option and licensing contracts to mergers & acquisitions.
Since then, the proposed international vaccine development fund has been discussed at the World Economic Forum in Davos, Switzerland, and both the National Academy of Medicine and the Foundation for Vaccine Research have expressed support for thvaccine development fund has been discussed at the World Economic Forum in Davos, Switzerland, and both the National Academy of Medicine and the Foundation for Vaccine Research have expressed support for thVaccine Research have expressed support for the idea.
Dr. Rabinovich has served in Chief of the Clinical and Regulatory Affairs Branch at the US National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical research units.
Blocking IL - 15 or IL - 15 signaling may be a way to restore oral tolerance to gluten and allow effective responses to vaccines aimed at preventing development of celiac disease, Jabri said.
He was chief of Microbiology and Immunology and of Vaccine Research and Development at the World Health Organization and was deeply involved in the coordination of research aiming at the development of vaccines against diseases of major Development at the World Health Organization and was deeply involved in the coordination of research aiming at the development of vaccines against diseases of major development of vaccines against diseases of major importance.
The two projects PRIMALVAC and PAMCPH / PlacMalVac aim at the development of a VAR2CSA based vaccine that could be administered to nulligravid women (before first pregnancy) thus inducing a state of protective immunity that is comparable to multigravid women and efficiently prevents subsequent episodes of placental malaria.
Joseph Rosen, a professor of surgery at Dartmouth College's Geisel School of Medicine and adjunct professor of engineering at Dartmouth's Thayer School of Engineering, describes the new approach to vaccine development as «revolutionary,» because it could dramatically reduce the amount of time needed to respond to disease outbreak.
If validated, the model will accelerate placental malaria vaccine development by facilitating quicker down - selection of vaccine candidates and providing safety data in pregnant primates at pre-clinical stage.
However, they said the development of the vaccine was timely, amid concerns the H5N1 bird flu strain circulating in south east Asia could mutate into a pandemic strain which would put millions of lives at risk.
While that may speed vaccine development, it wouldn't resolve the slowdown from growing vaccine inside chicken eggs, a decades - old technique that takes weeks to complete, Kristala Prather, assistant professor of chemical engineering at the Massachusetts Institute of Technology, told the panel.
Dr. Baldwin has been at IDRI for over six years and currently works on projects related to development of next - generation vaccines against infectious diseases.
a b c d e f g h i j k l m n o p q r s t u v w x y z